View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
January 7, 2016

Discover the trends in clinical trial activity from industry experts, GlobalData

New whitepaper released by Global Data explores and analyses the clinical trial landscape and provides details on trials planned for 2016.

By Staff Writer

This in-depth paper provides a preview and analysis of the clinical trials that are planned to be initiated in 2016. The data for the analyses are derived from the Clinical Trials Database of GlobalData’s Pharma eTrack platform, and the report provides a snapshot of the trials that have been recorded in the Clinical Trials Database as of December 10, 2015. Global Data’s informative white paper provides readers with an early landscape of the clinical trials planned for 2016, which includes analyses of the trial sponsors, the trial locations, and the leading drugs for which the trials are planned. These data will be of value especially to Clinical Research Organizations (CROs) for their business development needs, but also to all readers wishing to get an early read on the competitive landscape of clinical development programs worldwide.

The full whitepaper can be viewed free of charge on Global Data’s supplier page on here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena